Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001213900-24-070834
Filing Date
2024-08-20
Accepted
2024-08-19 18:39:21
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0208024-04.htm DEFR14A 1855003
2 GRAPHIC tallarity_logo.jpg GRAPHIC 57672
3 GRAPHIC tproxy_001.jpg GRAPHIC 1609477
4 GRAPHIC tproxy_002.jpg GRAPHIC 1414872
  Complete submission text file 0001213900-24-070834.txt   6101578
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-41160 | Film No.: 241222172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)